< Back to previous page
Researcher
Karin Haustermans
- Disciplines:Radiation therapy, Cancer diagnosis, Cancer therapy, Cancer epidemiology
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Responsible
From1 Jan 2012 → Today - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → Today
Infrastructure
1 - 1 of 1
- The PaRtiCLE proton center. (Consortium coordinator)
Projects
31 - 40 of 40
- DEVELOPMENT AND EVALUATION OF A WEB-BASED DECISION AIDFOR MEN BETWEEN THE AGE OF 65 AND 75 WITH LOCALIZED PROSTATE CANCER IN MAKING A TREATMENT CHOICEFrom1 Jul 2010 → 3 Apr 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization of the use of tyrosine kinase receptor inhibitors in the preoperative treatment for rectal cancer.From1 Mar 2010 → 28 Feb 2011Funding: BOF - Other initiatives
- Functional Peptidomics Knowledge Platform.From1 Oct 2009 → 30 Sep 2013Funding: IOF - Industrial Research Fund
- Implementation of functional imaging and molecular diagnostics for patient-tailored treatment of prostate cancer.From15 Sep 2009 → 30 Jun 2015Funding: Ministery of Social Affairs, Public Health and Environment
- The role of imaging in a patient-tailored approach for prostate cancerFrom1 Aug 2009 → 24 Jun 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of functional imaging and molecular profiling in image guided highly conformal radiotherapy for head and neck cancer: towards a patient tailored treatment.From1 Aug 2009 → 17 Dec 2013Funding: FWO fellowships
- Inter-university collaboration for building a Belgian Biobank network.From20 Jan 2009 → 31 Dec 2011Funding: Nonprofit institution or equivalents
- Implementation of functional imaging and molecular diagnostics for patient-tailored treatment of prostate cancer.From1 Jan 2009 → 30 Sep 2015Funding: Ministery of Social Affairs, Public Health and Environment
- A phase I dose-escalation study to determine the maximum tolerated dose of radiotherapy, in combination with concomitant 5-FU chemptherapy, in patients with locally advanced rectal cancer with a positive circumferential resection margin (cCRM).From1 Jan 2009 → 31 Dec 2010Funding: Private funding of national origin - undefined
- The combination of anti-angiogenic treatment with (chemo)radiotherapy in rectal tumours.From1 Jan 2008 → 31 Dec 2008Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 365
- Letter to the editor regarding "External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts" by M. Berbée et al.(2024)
Authors: Pieter Populaire, Karin Haustermans
Pages: 110175 - Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer(2024)
Authors: Pieter Populaire, Philippe Nafteux, Gilles Defraene, Karin Haustermans
- Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer(2024)
Authors: Karin Haustermans, Cédric Draulans
Pages: 66 - 73 - Clinical research for global needs of radiation oncology(2024)
Authors: Karin Haustermans
- Assessing late outcomes of advances in radiotherapy for paediatric cancers: Study protocol of the "HARMONIC-RT" European registry (NCT 04746729)(2024)
Authors: Karin Haustermans, Sandra Jacobs, Anne Uyttebroeck
- The use of electronic Patient Reported Outcomes in follow-up after palliative radiotherapy: A survey study in Belgium.(2023)
Authors: Eva Oldenburger, Chantal Van Audenhove, Karin Haustermans
Pages: 100243 - The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG)(2023)
Authors: Karin Haustermans
Pages: 1096 - 1106 - Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer(2023)
Authors: Pieter Populaire, Gilles Defraene, Philippe Nafteux, Lieven Depypere, Johnny Moons, Karin Haustermans
Pages: 1488 - 1495 - Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.(2023)
Authors: Karin Haustermans
Pages: 987 - 1002 - Patients' needs in proton therapy: A survey among ten European facilities(2023)
Authors: Karin Haustermans